Patent Assignment
Reel/Frame 030681/0784
Change of Name
Recorded: 2013-06-25
Pages: 4
Assignor
MERCK FROSST CANADA LTD.
Executed: 2011-01-01
Assignee
MERCK CANADA INC.
16711 TRANS-CANADA HIGHWAY, KIRKLAND, QUEBEC, H9H 3L1, CANADA
Covered Properties
(31)
Substituted Pyridines as Selective Cyclooxygenase-2 Inhibitors
Patent:
5,861,419 →
Application:
08/893,395 →
Methylsulfonyl Phenyl-2-(5H)-Furanones as Cox-2 Inhibitors
Patent:
5,981,576 →
Application:
09/097,537 →
(Methylsulfonyl)Phenyl-2(5H)-Furanones as Cox-2 Inhibitors
Patent:
6,020,343 →
Application:
09/097,543 →
Substituted Pyridines as Selective Cyclooxygenase-2 Inhibitors
Patent:
6,001,843 →
Application:
09/181,887 →
Substituted Pyridines as Selective Cyclooxygenase-2 Inhibitors
Patent:
6,071,936 →
Application:
09/312,790 →
Substituted Pyridines as Selective Cyclooxygenase-2 Inhibitors
Sulphonamido-Substituted Bridged Bicycloalkyl Derivatives
Cathepsin Cysteine Protease Inhibitors
Pyridopyrrolizine and Pyridoindolizine Derivatives
Cathepsin Cysteine Protease Inhibitors
4-Oxo-1-(3-Substituted Phenyl-1,4-Dihydro-1,8-Naphthyridine-3-Carboxamide Phosphodiesterase-4 Inhibitors
EP4 Receptor Agonist, Compositions and Methods Thereof
Substituted Pyridines as Selective Cyclooxygenase-2 Inhibitors
EP4 Receptor Agonist, Compositions and Methods Thereof
Synthesis of Alpha Fluoroalkyl Amines
Novel Pharmaceutical Compounds
EP4 Receptor Agonist, Compositions and Methods Thereof
Patent:
42,562 →
Application:
11/796,044 →
Composition for Inhibition of Cathepsin K
Cathepsin Cysteine Protease Inhibitors
Indole Derivatives as CRTH2 Receptor Antagonists
Azacycloalkane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
Indole Amide Derivatives as EP4 Receptor Ligands
2-(Phenyl or Heterocyclic)-1H-Phenantrho[9,10-D]Imidazoles as Mpges-1 Inhibitors
Formulations for Cathepsin K Inhibitors
Application:
12/527,876 →
Publication:
US 2009/0318560
Combination Therapy
Application:
12/738,946 →
Publication:
US 2010/0210611
Cysteine Protease Inhibitors for the Treatment of Parasitic Disease
Application:
12/745,070 →
Publication:
US 2010/0305056
Process for the Preparation of an Orexin Receptor Antagonist
Azetidine Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
Application:
13/121,786 →
Publication:
US 2011/0183958
Renin Inhibitors
Application:
13/262,781 →
Publication:
US 2012/0035214
Cathepsin Cysteine Protease Inhibitors for the Treatment of Various Diseases
Application:
13/379,200 →
Publication:
US 2012/0101053
Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jan 26, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023906/0803 →
Assignment of Assignor's Interest
Feb 11, 2010
From: BOYD, MICHAEL; LAU, CHEUK; MELLON, CHRISTOPHE; ROY, BRUNO
To: MERCK FROSST CANADA & CO.
Reel/Frame 023924/0766 →
Change of Name
Feb 23, 2010
From: MERCK FROSST CANADA & CO.
To: MERCK FROSST CANADA LTD.
Reel/Frame 023976/0526 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →